Table 3 Serum miRNA expression associated with 2-year disease free survival in patients with primary glioblastoma

microRNAs

Adj. HR (95% CI)^a

P value

Adj. HR (95% CI)^a

P value

Adj. HR (95% CI)^a

P value

miR-922

1.78 (1.09, 4.62)

0.040

1.39 (0.65, 3.72)

0.506

1.61 (0.75, 3.29)

0.369

miR-222-3p

1.77 (1.07, 4.85)

0.043

1.61 (1.02, 3.94)

0.046

1.71 (1.07, 3.63)

0.038

miR-20a-5p

1.66 (1.06, 4.45)

0.044

1.68 (1.02, 3.72)

0.045

1.68 (1.05, 3.81)

0.040

miR-106a-5p

1.61 (1.05, 4.39)

0.046

1.71 (1.09, 3.69)

0.039

1.72 (1.04, 3.76)

0.047

miR-124a

0.69 (0.27, 1.05)

0.084

0.63 (0.22, 0.97)

0.048

0.65 (0.26, 1.03)

0.062

miR-182

0.68 (0.28, 0.96)

0.047

0.67 (0.28, 0.97)

0.048

0.69 (0.30, 0.94)

0.043

miR-548a

0.68 (0.28, 0.99)

0.049

0.70 (0.29, 1.16)

0.242

0.61 (0.32, 1.04)

0.106

miR-371a-5p

0.64 (0.27, 1.26)

0.379

0.62 (0.29, 0.99)

0.049

0.62 (0.30, 1.05)

0.098

miR-145-5p

0.62 (0.28, 0.99)

0.049

0.56 (0.27, 0.97)

0.047

0.60 (0.32, 0.92)

0.039